Global HIV/AIDS Diagnostics Market 2017-2022: Supplier Country Shares, Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures--HIV 1/2, Combo, Ag, NAT, Western Blot--Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs

January 2018 | 288 pages | ID: G0DD689113AEN
Venture Planning Group

Abstracts

Complete report $5,450. DataPack (test volumes, sales forecasts, supplier shares) $3,500.

Summary

This 7-country report presents detailed analyses of the AIDS diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:

• Hospitals
• Commercial/Private Laboratories
• Blood Banks
• Physician Offices
• Public Health Laboratories

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

• Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
• Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
• Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter, bioMerieux, Ortho Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
• Profiles over 30 leading manufacturers and potential market entrants developing innovative technologies and products.
• Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including VPGMarketResearchs proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 288 pages and 43 tables

Contents

I. INTRODUCTION

II. WORLDWIDE TEST OVERVIEW, TECHNOLOGIES AND INSTRUMENTATION

A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Infectious Disease Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. MOLECULAR DIAGNOSTICS
2. MONOCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. DIFFERENTIAL LIGHT SCATTERING
5. INFORMATION TECHNOLOGY
6. ARTIFICIAL INTELLIGENCE
7. LIPOSOMES
8. FLOW CYTOMETRY
9. CHROMATOGRAPHY
10. DIAGNOSTIC IMAGING
11. GEL MICRODROPLETS
12. OTHERS
D. Personal Testing

III. COUNTRY ANALYSES: SALES AND VOLUME FORECASTS

A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products

V. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

VII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher/Life Technology
Wallac/PE
Wako